JASON KANIA has 20+ years of experience improving businesses and investments. In stark contrast to others, Jason has founded and sold two companies and understands what it takes to build a successful company and to exit successfully. Jason has delivered products and sales programs that have generated $500+ million in revenue and saved $6 billion in expenses. Additionally, Jason has overseen the acquisition or sale of 75+ low- to mid-market companies with a combined enterprise value of $550+ million.
Jason continues to invest and mentor startups from Techstars, UChicago, Virginia Tech among others. Jason currently serves on the Board of Directors of Anterra and Head Health. Jason earned a Bachelor of Science degree cum laude from Virginia Tech and an MBA from the University of Chicago. LinkedIn
DR. OMAR SINNO has 12+ years of experience in pharmaceuticals and medicine.
Dr. Sinno is currently the Rare Disease Medical Lead for UCB. Previously Dr. Sinno served as the Chief Medical Officer for Unite Genomics, led Medical Affairs for AltaThera Pharmaceuticals and as a Medical Liaison for Amgen.
Dr. Sinno is a graduate of the Loyola University Stritch School of Medicine and holds an MBA from the University of Chicago Booth School of Business. LinkedIn
